Regenerative Medicine: Regulatory, Legal, and Compliance Challenges for Cell and Gene Therapies
Food and Drug Law Institute
Jun
8
2021
Date: June 8, 2021
Time: 1:05PM - 1:50PM (EST)
Location: Online Event
Joanne Hawana will be speaking on a panel titled, "Updates on FDA’s Comprehensive Regenerative Medicine Policy Framework," at FDLI's Regenerative Medicine: Regulatory, Legal, and Compliance Challenges for Cell and Gene Therapies Conference on June 8. The session will examine FDA's framework for supporting and expediting regenerative medicine product development, including the status of new and upcoming guidances.
Speakers
Joanne S. Hawana
Panelist
Joanne counsels global clients on the regulatory and distribution-related implications when bringing a new FDA-regulated product to market and how to ensure continued compliance after a product is commercialized.